Ryan Reed – Homestead Advance

Team: No. 16 Drive Down A1C Lilly Diabetes Ford Mustang
Crew Chief: Phil Gould
Twitter: @driverRyanReed, @Reed16Team and @RoushFenway


Reed at Homestead

Ryan Reed will make his sixth NASCAR Xfinity Series (NXS) start at Homestead-Miami Speedway this weekend. In his five previous starts, Reed’s best finish of 13th came in 2013. Reed has an average starting position of 15th and an average finish of 18.6 at the 1.5-mile track.

Homestead 2017

Ryan Reed closed out the 2017 NASCAR Xfinity Series season eighth in the driver standings following his 20th-place finish in the season finale at Homestead-Miami Speedway. Reed had a fast No. 16 Lilly Diabetes Ford, but was assessed a pass through penalty after avoiding a car sideways in front of him at the start of the race. A caution never fell his way to get back on the lead lap.


Ryan Reed and Lilly Diabetes are encouraging and motivating NASCAR fans to better manage their diabetes by visiting www.DriveDownA1C.com to learn more about resources and treatment options.

Did You Know?

Ryan Reed was diagnosed at the age of 17 with Type 1 Diabetes. Through hard work, perseverance and working with his doctors he’s been able to manage his diabetes and set an example to others.

Reed on Homestead

“Homestead is really demanding, it’s so worn out and we run right up against the fence. It’s just one of those tracks that every driver looks forward to going there just because it’s worn out, drivers track, everything that a driver talks about that he wants to feel in a racetrack, that place has it. It’s our only true 1.5-mile oval, it’s unique, we don’t go to very many places like it.”

About Lilly Diabetes

Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing we strive to make life better for people affected by diabetes. We offer a wide range of therapies and a continued determination to provide real solutions—from medicines and technologies to support programs and more. For the latest updates, visit http://www.lillydiabetes.com/ or follow us on Twitter: @LillyDiabetes and Facebook: LillyDiabetesUS.


Please enter your comment!
Please enter your name here